SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-13-189475
Filing Date
2013-05-01
Accepted
2013-05-01 06:09:06
Documents
2
Group Members
CHARLES R. KAYEJOSEPH P. LANDYWARBURG PINCUS & CO.WARBURG PINCUS LLCWARBURG PINCUS PARTNERS LLCWARBURG PINCUS X LLCWARBURG PINCUS X PARTNERS, L.P.WARBURG PINCUS X, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 9 d527940dsc13da.htm SC 13D/A 165393
2 EX-99.8 d527940dex998.htm EX-99.8 77057
  Complete submission text file 0001193125-13-189475.txt   244394
Mailing Address NO.14 EAST HUSHAN ROAD TAI'AN CITY, SHANDONG F4 271000
Business Address NO.14 EAST HUSHAN ROAD TAI'AN CITY, SHANDONG F4 271000 86-538-620-3897
China Biologic Products, Inc. (Subject) CIK: 0001369868 (see all company filings)

IRS No.: 752308816 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83122 | Film No.: 13800273
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017
Business Address C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 212-878-0600
Warburg Pincus Private Equity X, L.P. (Filed by) CIK: 0001414565 (see all company filings)

IRS No.: 260849130 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A